NALP3 Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms (NCT00487708) | Novartis Pharmaceuticals | 2005-01-01 |
Track NALP3 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.